Health-ISAC warns of rising cyber threats to Brazil’s healthcare sector, urging better intelligence sharing to protect patient data and infrastructure.
Acquisitions Increase Growth Outlook
(in U.S. dollars unless otherwise noted)
TORONTO, Aug. 9, 2025 /PRNewswire/ - "I am very pleased with our record financial results this...
WASHINGTON, Aug. 8, 2025 /PRNewswire/ -- The U.S. Postal Service filed notice today with the Postal Regulatory Commission (PRC) regarding a temporary price change for...
Dramatically Enhanced Program Streamlines Engagement and Empowers Partners to Fuel Profitable Growth, Technical Strength, and Differentiation
SINGAPORE, Aug. 8, 2025 /PRNewswire/ -- Cohesity, the leader...
DENVER, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Leading cryptocurrency trading platform XXKK Exchange officially announces the launch of its fully upgraded web trading platform. This upgrade centers on enhancing user experience across key areas including account registration, KYC verification, crypto trading operations, digital asset management, security, and customer support. The new platform significantly improves the efficiency and safety of trading major cryptocurrencies such as Bitcoin, USDT, and Ethereum, empowering users to manage their digital assets smarter and more conveniently.
SYDNEY, Aug. 7, 2025 /PRNewswire/ -- Saasyan has rolled out its new Parent Portal, now available to schools using its AI-powered student safety solution,...
New direct admission program offers eligible students a streamlined pathway to higher education
RALEIGH, N.C., Aug. 6, 2025 /PRNewswire/ -- Starting this fall, more than 62,000 North...
Decentralised EV charging startup empowers local hosts and fleets to monetize unused spaces with smart chargers, starting with high-traffic commercial locations in the DMV...
BEIJING, Aug. 4, 2025 /PRNewswire/ -- Sohu.com Limited (NASDAQ: SOHU) ("Sohu" or the "Company"), a leading Chinese online media platform and game business group, today...
Basel, 01 August 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today new, five-year efficacy, safety and durability data from the Phase III Portal study, a long-term extension of the Phase III Archway study, of Susvimo® (ranibizumab injection) for the treatment of people with nAMD.1 Results show that Susvimo’s immediate and predictable durability was sustained over five years, with approximately 95% of people receiving treatment every six months requiring no supplemental treatment before each refill. The data were presented at the American Society of Retina Specialists (ASRS) 2025 Annual Meeting in Long Beach, California, United States.
ARLINGTON, Va., Aug. 1, 2025 /PRNewswire/ -- Pro Football Retired Players Association (PFRPA), a national organization that develops programs and benefits for retired NFL...
DELRAY BEACH, Fla., Aug 1, 2025 /PRNewswire/ --According to MarketsandMarkets™, the Software-defined Wide Area Network Market is expected to grow to USD 21.67 billion by 2030...